Annual EBITDA
-$7.81 M
-$13.37 M-240.56%
01 December 2023
Summary:
TC Biopharm (Holdings) annual earnings before interest, taxes, depreciation & amortization is currently -$7.81 million, with the most recent change of -$13.37 million (-240.56%) on 01 December 2023. During the last 3 years, it has fallen by -$1.06 million (-15.69%). TCBP annual EBITDA is now -240.56% below its all-time high of $5.56 million, reached on 31 December 2022.TCBP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.20 M
-$9.49 M-179.57%
01 March 2024
Summary:
TC Biopharm (Holdings) quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.20 million, with the most recent change of -$9.49 million (-179.57%) on 01 March 2024. Over the past year, it has dropped by -$9.49 million (-179.57%). TCBP quarterly EBITDA is now -179.57% below its all-time high of $5.28 million, reached on 01 June 2023.TCBP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$1.08 M
+$639.20 K+145.14%
01 March 2024
Summary:
TC Biopharm (Holdings) TTM earnings before interest, taxes, depreciation & amortization is currently $1.08 million, with the most recent change of +$639.20 thousand (+145.14%) on 01 March 2024. Over the past year, it has increased by +$639.20 thousand (+145.14%). TCBP TTM EBITDA is now at all-time high.TCBP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCBP EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -240.6% | -179.6% | +145.1% |
3 y3 years | -15.7% | +48.3% | +110.9% |
5 y5 years | - | - | - |
TCBP EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -240.6% | +46.0% | -179.6% | +48.3% | at high | +109.5% |
5 y | 5 years | -240.6% | +46.0% | -179.6% | +48.3% | at high | +109.5% |
alltime | all time | -240.6% | +46.0% | -179.6% | +48.3% | at high | +109.5% |
TC Biopharm (Holdings) EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2024 | - | -$4.20 M(-179.6%) | $1.08 M(+145.1%) |
Dec 2023 | -$7.81 M(-240.6%) | - | - |
June 2023 | - | $5.28 M(-209.1%) | $440.40 K(-109.1%) |
Mar 2023 | - | -$4.84 M | -$4.84 M |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | $5.56 M(-138.4%) | - | - |
Dec 2021 | -$14.47 M(+114.3%) | -$3.17 M(-61.1%) | -$11.30 M(+14.0%) |
Sept 2021 | - | -$8.13 M(+358.1%) | -$9.91 M(+458.1%) |
Dec 2020 | -$6.75 M(-7.4%) | -$1.78 M | -$1.78 M |
Dec 2019 | -$7.30 M | - | - |
FAQ
- What is TC Biopharm (Holdings) annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for TC Biopharm (Holdings)?
- What is TC Biopharm (Holdings) annual EBITDA year-on-year change?
- What is TC Biopharm (Holdings) quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for TC Biopharm (Holdings)?
- What is TC Biopharm (Holdings) quarterly EBITDA year-on-year change?
- What is TC Biopharm (Holdings) TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for TC Biopharm (Holdings)?
- What is TC Biopharm (Holdings) TTM EBITDA year-on-year change?
What is TC Biopharm (Holdings) annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TCBP is -$7.81 M
What is the all time high annual EBITDA for TC Biopharm (Holdings)?
TC Biopharm (Holdings) all-time high annual earnings before interest, taxes, depreciation & amortization is $5.56 M
What is TC Biopharm (Holdings) annual EBITDA year-on-year change?
Over the past year, TCBP annual earnings before interest, taxes, depreciation & amortization has changed by -$13.37 M (-240.56%)
What is TC Biopharm (Holdings) quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TCBP is -$4.20 M
What is the all time high quarterly EBITDA for TC Biopharm (Holdings)?
TC Biopharm (Holdings) all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.28 M
What is TC Biopharm (Holdings) quarterly EBITDA year-on-year change?
Over the past year, TCBP quarterly earnings before interest, taxes, depreciation & amortization has changed by -$9.49 M (-179.57%)
What is TC Biopharm (Holdings) TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TCBP is $1.08 M
What is the all time high TTM EBITDA for TC Biopharm (Holdings)?
TC Biopharm (Holdings) all-time high TTM earnings before interest, taxes, depreciation & amortization is $1.08 M
What is TC Biopharm (Holdings) TTM EBITDA year-on-year change?
Over the past year, TCBP TTM earnings before interest, taxes, depreciation & amortization has changed by +$639.20 K (+145.14%)